Latest news
Loading news…
Lundbeck
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Valby, Hovedstaden, Denmark Founded 2000 5001-10000 employees For Profit
Lundbeck is a pharmaceutical company that develops products to treat people with psychiatric and neurological disorders.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
9
Investments
5
2 exits
Monthly Visits
Available in Pro Contacts
1,192
Ticker
LUN
CPH - Copenhagen Stock Exchange
Patents
586
529 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- LUN
- Exchange
- CPH - Copenhagen Stock Exchange
- IPO date
- Jun 18, 1999
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 95
- Mobile apps
- 1
- Active products
- 18
- Patents granted
- 586
- Trademarks
- 529
- Top patent class
- Organic Chemistry
- IT spend
- $67.27M
Investor Activity
- Investments
- 5
- Lead investments
- 1
- Portfolio orgs
- 3
- Exits
- 2
- Exits via IPO
- 1
Company Info
- Founded
- 2000
- Employees
- 5001-10000
- Operating status
- Active
- Company type
- For Profit
- Org types
- company, investor
- Founders
- 2
- Sub-organizations
- 1
- News articles
- 472
- HQ
- Valby, Hovedstaden, Denmark
- Region
- European Union (EU), Nordic Countries, Scandinavia
- Exit date
- Jun 18, 1999
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.3
- Trend (30d)
- 1.7
- Trend (90d)
- 6.2
- Last leadership hire
- Jul 1, 2026
- Last layoff mention
- Nov 27, 2025
Investments by Lundbeck
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by Lundbeck
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Lundbeck
Senior Vice President, Head of Clinical Development
Senior Vice President Supply Chain
President & Chief Executive Officer
Divisional Director Clinical & Quantitativ Pharmacology
EVP of commercial and corporate strategy
EVP, Head of Lundbeck US and President
Executive Vice President, Product Development & Supply
Vice President
Vice President, Head of Experimental Medicine
President
Executive Vice President
Senior Vice President and Chief AI Officer
Director, Corporate Business Development & Strategy
1,192
professional contacts at Lundbeck
Contact execs at Lundbeck →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Lundbeck
Loading news…
FAQs about Lundbeck
People who checked this page also checked these
Sectors Lundbeck invests & acquires in
Browse the full Acquirezy directory.